Stay updated on Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A newer revision number (v3.6.2) is now shown, indicating a behind-the-scenes update to the site. This update does not modify the study information displayed on the page.
    Difference
    0.0%
    Check dated 2026-06-27T05:34:57.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    New navigation/help sections such as How to Read a Study Record, Common Questions, and How to Join a Study were added, and a version update indicates v3.6.0. The investigator name presentation and related metadata were adjusted (e.g., William Gradishar entry and related labels).
    Difference
    1%
    Check dated 2026-06-13T00:20:30.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a minor page update or bug fix. It does not appear to modify the study details, eligibility criteria, or results on the page.
    Difference
    0.1%
    Check dated 2026-06-05T22:04:45.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.3 to v3.5.4. This update is a metadata/version bump and does not change the study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-05-15T14:19:50.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from v3.5.2 to v3.5.3, reflecting a site interface update rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:21:12.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:50:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine in TNBC/HR+ Breast Cancer Clinical Trial page.